Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haoling H Weng

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Arthritis and Rheumatism|September 2, 2006
Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosusXuebing Feng, Hui Wu, Jennifer M Grossman, et al.
Rheumatology (Oxford, England)|April 27, 2016
Prediction of remission and low disease activity in disease-modifying anti-rheumatic drug-refractory patients with rheumatoid arthritis treated with golimumabNathan Vastesaeger, Abraham Garcia Kutzbach, Howard Amital, et al.
JCI Insight|November 8, 2024
SLC6A19 inhibition facilitates urinary neutral amino acid excretion and lowers plasma phenylalanineHeike J Wobst, Andreu Viader, Giovanni Muncipinto, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Arthritis and Rheumatism|September 2, 2006
Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosusXuebing Feng, Hui Wu, Jennifer M Grossman, et al.
Rheumatology (Oxford, England)|April 27, 2016
Prediction of remission and low disease activity in disease-modifying anti-rheumatic drug-refractory patients with rheumatoid arthritis treated with golimumabNathan Vastesaeger, Abraham Garcia Kutzbach, Howard Amital, et al.
JCI Insight|November 8, 2024
SLC6A19 inhibition facilitates urinary neutral amino acid excretion and lowers plasma phenylalanineHeike J Wobst, Andreu Viader, Giovanni Muncipinto, et al.
Pageof 3